Pediatric nonalcoholic fatty liver disease - a changing diagnostic paradigm

Area of Science:

• Hepatology
• Pediatric Gastroenterology
• Public Health

Background:

• Nonalcoholic fatty liver disease (NAFLD) is the predominant cause of chronic liver disease in children and adolescents globally.
• Increasing rates of childhood obesity and overweight correlate directly with the rising prevalence of pediatric NAFLD.
• NAFLD in children presents a significant public health challenge requiring effective management strategies.

Purpose of the Study:

• To review and emphasize the primary diagnostic tools for nonalcoholic fatty liver disease in pediatric populations.
• To highlight the need for noninvasive biomarkers and screening techniques for early detection of pediatric NAFLD.
• To underscore the importance of early diagnosis for preventing future metabolic and cardiovascular complications.

Main Methods:

• Review of current literature on diagnostic approaches for pediatric NAFLD.
• Analysis of non-invasive strategies, including ultrasound and biochemical markers (transaminases).
• Discussion of liver biopsy as a diagnostic tool for histological assessment.

Main Results:

• Pediatric NAFLD diagnosis is often suggested by liver hyperechogenicity on ultrasound or elevated transaminases.
• Liver biopsy provides specific histological findings distinct from adult NAFLD.
• The clinical heterogeneity of NAFLD necessitates improved diagnostic methods.

Conclusions:

• Early identification of pediatric NAFLD is critical due to its systemic nature and multifactorial pathogenesis.
• Development of noninvasive biomarkers and advanced screening techniques is imperative for timely diagnosis.
• Effective management of pediatric NAFLD is essential to mitigate long-term health risks into adulthood.